Tendon problems only temporarily soothed by cortisone injections

Oct 26, 2010

(PhysOrg.com) -- Cortisone injections which offer short term relief for painful tendon problems, such as tennis elbow, can actually prolong the condition, a University of Queensland study has shown.

Professor of Sports Physiotherapy with UQ's School of Health and Rehabilitation Sciences Bill Vicenzino said the study showed doctors should be advising patients there were more effective treatments available.

“There is a tendency for the majority (70-90 per cent) of those following a wait-and-see policy to get better at six to 12 months, but this is not the case with steroid injection - they tend to lag behind these time frames significantly,“ Professor Vicenzino said.

“Doctors should indicate that while these injections produce rapid improvements they are short lived in the majority of patients with a high risk of recurrence of the condition and long term poor outcomes compared to adopting a wait-and-see policy.”

Overuse disorders of tendon or tendinopathies affect active young (20-30-year-old) people and middle-aged (40-60-year-old) people and are often difficult to manage successfully.

Professor Vicenzino said the condition was much more likely to return (64 per cent) after corticosteroid injections than for a physiotherapy program of mobilisation with movements and exercise.

“In general, tendon problems should not be injected without first having had a trial of exercise, which should be given two to three months to take effect.”

The study, which is part of Ms Brooke Coombes' PhD candidature, reviewed the results of 41 previously published studies, including 2672 patients with various tendon problems.

Professor Vicenzino said many new injections had not been studied and required further in-depth investigations, as did the benefits of combining injections and physiotherapy.

“More work is needed before we can be confident in strongly recommending a treatment," he said.

"There is solid evidence that whatever passive treatment is used (such as injections, gene therapy, laser, mobilisation with movements, etc.) it is likely to fail in the long term if exercise is not part of the management plan."

Explore further: Recorded Ebola deaths top 7,000

More information: More information: www.thelancet.com/journals/lan… (10)61160-9/abstract

add to favorites email to friend print save as pdf

Related Stories

Surgery may not be necessary for Achilles tendon rupture

May 14, 2009

The two ends of a ruptured Achilles tendon are often stitched together before the leg is put in plaster, in order to reduce the risk of the tendon rupturing again. However, Katarina Nilsson Helander, MD, PhD at the Sahlgrenska ...

New pill to treat multiple sclerosis

Apr 30, 2009

A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.

Recommended for you

Recorded Ebola deaths top 7,000

11 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

15 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.